These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both? Afdhal NH JAMA; 2012 Aug; 308(6):608-16. PubMed ID: 22760235 [TBL] [Abstract][Full Text] [Related]
24. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Kunde SS; Lazenby AJ; Clements RH; Abrams GA Hepatology; 2005 Sep; 42(3):650-6. PubMed ID: 16037946 [TBL] [Abstract][Full Text] [Related]
25. Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis. Kwon YD; Ko KO; Lim JW; Cheon EJ; Song YH; Yoon JM J Korean Med Sci; 2019 Jun; 34(23):e165. PubMed ID: 31197983 [TBL] [Abstract][Full Text] [Related]
26. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse. Sterling RK; Smith PG; Brunt EM J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409 [TBL] [Abstract][Full Text] [Related]
27. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis. Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638 [TBL] [Abstract][Full Text] [Related]
28. [Clinical and histological features of non-alcoholic fatty liver disease]. Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638 [TBL] [Abstract][Full Text] [Related]
29. The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease. Margariti A; Deutsch M; Manolakopoulos S; Tiniakos D; Papatheodoridis GV J Clin Gastroenterol; 2013 Mar; 47(3):280-6. PubMed ID: 23391869 [TBL] [Abstract][Full Text] [Related]
30. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. Schwimmer JB; Deutsch R; Rauch JB; Behling C; Newbury R; Lavine JE J Pediatr; 2003 Oct; 143(4):500-5. PubMed ID: 14571229 [TBL] [Abstract][Full Text] [Related]
32. Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease. Petta S; Wai-Sun Wong V; Bugianesi E; Fracanzani AL; Cammà C; Hiriart JB; Lai-Hung Wong G; Vergniol J; Wing-Hung Chan A; Giannetti A; Merrouche W; Lik-Yuen Chan H; Le-Bail B; Lombardi R; Guastella S; Craxì A; de Ledinghen V Am J Gastroenterol; 2019 Jun; 114(6):916-928. PubMed ID: 31169533 [TBL] [Abstract][Full Text] [Related]
33. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. Sreenivasa Baba C; Alexander G; Kalyani B; Pandey R; Rastogi S; Pandey A; Choudhuri G J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):191-8. PubMed ID: 16706832 [TBL] [Abstract][Full Text] [Related]
34. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration. Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083 [TBL] [Abstract][Full Text] [Related]
35. Obese boys at increased risk for nonalcoholic liver disease: evaluation of 16,390 overweight or obese children and adolescents. Wiegand S; Keller KM; Röbl M; L'Allemand D; Reinehr T; Widhalm K; Holl RW; Int J Obes (Lond); 2010 Oct; 34(10):1468-74. PubMed ID: 20531349 [TBL] [Abstract][Full Text] [Related]
36. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473 [TBL] [Abstract][Full Text] [Related]
37. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. Sumida Y; Yoneda M; Hyogo H; Itoh Y; Ono M; Fujii H; Eguchi Y; Suzuki Y; Aoki N; Kanemasa K; Fujita K; Chayama K; Saibara T; Kawada N; Fujimoto K; Kohgo Y; Yoshikawa T; Okanoue T; BMC Gastroenterol; 2012 Jan; 12():2. PubMed ID: 22221544 [TBL] [Abstract][Full Text] [Related]
38. Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). Raszeja-Wyszomirska J; Szymanik B; Ławniczak M; Kajor M; Chwist A; Milkiewicz P; Hartleb M BMC Gastroenterol; 2010 Jun; 10():67. PubMed ID: 20584330 [TBL] [Abstract][Full Text] [Related]
39. Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity. Puljiz Z; Stimac D; Kovac D; Puljiz M; Bratanić A; Kovacić V; Kardum D; Bonacin D; Hozo I Coll Antropol; 2010 Mar; 34 Suppl 1():33-7. PubMed ID: 20402293 [TBL] [Abstract][Full Text] [Related]
40. Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease. Sonmez A; Nikolic D; Dogru T; Ercin CN; Genc H; Cesur M; Tapan S; Karslioğlu Y; Montalto G; Banach M; Toth PP; Bagci S; Rizzo M J Clin Lipidol; 2015; 9(4):576-82. PubMed ID: 26228676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]